title: Rapid and contrasting effects of rosiglitazone on transient receptor potential TRPM3 and TRPC5 channels.
abstract: The aim of this study was to generate new insight into chemical regulation of transient receptor potential (TRP) channels with relevance to glucose homeostasis and the metabolic syndrome. Human TRP melastatin 2 (TRPM2), TRPM3, and TRP canonical 5 (TRPC5) were conditionally overexpressed in human embryonic kidney 293 cells and studied by using calcium-measurement and patch-clamp techniques. Rosiglitazone and other peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists were investigated. TRPM2 was unaffected by rosiglitazone at concentrations up to 10 μM but was inhibited completely at higher concentrations (IC(50), ∼22.5 μM). TRPM3 was more potently inhibited, with effects occurring in a biphasic concentration-dependent manner such that there was approximately 20% inhibition at low concentrations (0.1-1 μM) and full inhibition at higher concentrations (IC(50), 5-10 μM). PPAR-γ antagonism by 2-chloro-5-nitrobenzanilide (GW9662) did not prevent inhibition of TRPM3 by rosiglitazone. TRPC5 was strongly stimulated by rosiglitazone at concentrations of ≥10 μM (EC(50), ∼30 μM). Effects on TRPM3 and TRPC5 occurred rapidly and reversibly. Troglitazone and pioglitazone inhibited TRPM3 (IC(50), 12 μM) but lacked effect on TRPC5, suggesting no relevance of PPAR-γ or the thiazolidinedione moiety to rosiglitazone stimulation of TRPC5. A rosiglitazone-related but nonthiazolidinedione PPAR-γ agonist, N-(2-benzoylphenyl)-O-[2-(methyl-2-pyridinylamino)ethyl]-l-tyrosine (GW1929), was a weak stimulator of TRPM3 and TRPC5. The natural PPAR-γ agonist 15-deoxy prostaglandin J(2), had no effect on TRPM3 or TRPC5. The data suggest that rosiglitazone contains chemical moieties that rapidly, strongly, and differentially modulate TRP channels independently of PPAR-γ, potentially contributing to biological consequences of the agent and providing the basis for novel TRP channel pharmacology.
authors.affiliation: Multidisciplinary Cardiovascular Research Centre and Institute of Membrane and Systems Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.
authors.forename: Yasser
authors.initials: Y
authors.lastname: Majeed
authors.forename: Yahya
authors.initials: Y
authors.lastname: Bahnasi
authors.forename: Victoria A L
authors.initials: VA
authors.lastname: Seymour
authors.forename: Lesley A
authors.initials: LA
authors.lastname: Wilson
authors.forename: Carol J
authors.initials: CJ
authors.lastname: Milligan
authors.forename: Anil K
authors.initials: AK
authors.lastname: Agarwal
authors.forename: Piruthivi
authors.initials: P
authors.lastname: Sukumar
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Naylor
authors.forename: David J
authors.initials: DJ
authors.lastname: Beech
mesh_terms: D002118:Calcium / Q000378:metabolism; D002460:Cell Line; D006801:Humans; D018408:Patch-Clamp Techniques; D000077154:Rosiglitazone; D050052:TRPC Cation Channels / Q000187:drug effects*; D050053:TRPM Cation Channels / Q000187:drug effects*; D045162:Thiazolidinediones / Q000494:pharmacology*
chemical_list: D050052:TRPC Cation Channels; C491780:TRPC5 protein, human; D050053:TRPM Cation Channels; C475667:TRPM3 protein, human; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D002118:Calcium